Drug Shortage Report for VITAMIN C
Report ID | 238430 |
Drug Identification Number | 02245214 |
Brand name | VITAMIN C |
Common or Proper name | ASCORBIC ACID |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | ASCORBIC ACID |
Strength(s) | 500MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 50ML 1VL |
ATC code | A11GA |
ATC description | ASCORBIC ACID (VIT C), INCL COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-09-25 |
Actual start date | 2024-10-02 |
Estimated end date | 2025-01-14 |
Actual end date | 2025-01-16 |
Shortage status | Resolved |
Updated date | 2025-01-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-09-24 | French | Compare |
v1 | 2024-09-24 | English | Compare |